We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
Abbott Diagnostics

Download Mobile App





Vela Diagnostics to Offer Manual ViroKey SARS-CoV-2 RT-PCR Test

By LabMedica International staff writers
Posted on 04 Apr 2020
Print article
Image: Applied Biosystems 7500 Fast Dx Real-Time PCR Instrument (Photo courtesy of Applied Biosystems)
Image: Applied Biosystems 7500 Fast Dx Real-Time PCR Instrument (Photo courtesy of Applied Biosystems)
Vela Diagnostics (Singapore) plans to offer its manual ViroKey SARS-CoV-2 RT-PCR Test after its validation is completed and is currently working with the US Food and Drug Administration (FDA) for securing Emergency Use Authorization (EUA) for the test. Vela is a provider of an automated IVD Next–Generation Sequencing (NGS) workflow in the global diagnostics market. VELA’s real-time PCR and NGS applications are available on an integrated Sentosa platform; this provides a unique ability to leverage one system for two workflows, while carrying out tests for various targets in order to answer current clinical and research questions, as well as to drive laboratory operational efficiency.

Vela’s ViroKey SARS-CoV-2 RT-PCR Test is a real-time RT-PCR test intended for the qualitative detection of nucleic acid from the SARS-CoV-2 in nasopharyngeal and oropharyngeal swabs from individuals meeting CDC SARS-CoV-2 clinical criteria (e.g., clinical signs and symptoms associated with SARS-CoV-2 infection) in conjunction with CDC SARS-CoV-2 epidemiological criteria (e.g., history of residence in, or travel to a geographic region with active SARS-CoV-2 transmission at the time of travel, or other epidemiologic criteria for which SARS-CoV-2 testing may be indicated).

The automated workflow is intended to be used on the Sentosa SX101 with the Sentosa SX Virus Total Nucleic Acid Kit v2.0 in conjunction with the Sentosa SA201 instrument for high-throughput RT-PCR. The assay also fits into a manual workflow for laboratories with existing Applied Biosystems 7500 Fast Dx Real-Time PCR Instrument.

Related Links:
Vela Diagnostics


Print article

Channels

Molecular Diagnostics

view channel
Image: Pre-eclampsia: high magnification micrograph of hypertrophic decidual vasculopathy, as seen in pregnancy-induced hypertension. (Photo courtesy of Wikimedia Commons)

Serum MicroRNAs Predict Likelihood of Pregnant Women Developing Pre-Eclampsia

MicroRNA biomarkers have been identified in the blood of asymptomatic pregnant women that can be used to predict the potential onset of pre-eclampsia. Pre-eclampsia (PE) is a disorder of pregnancy characterized... Read more

Microbiology

view channel
Image: Stenotrophomonas maltophilia colonies on sheep blood agar. Cultivation 48 hours in an aerobic atmosphere, 37 °C (Photo courtesy of microbiologyinpictures).

Global Spread of the Multi-Resistant Pathogen Stenotrophomonas Maltophilia Revealed

Stenotrophomonas maltophilia strains occur in several natural and human associated ecosystems. The bacterium was long regarded as relatively unproblematic, but is now considered to be one of the most feared... Read more
Copyright © 2000-2020 Globetech Media. All rights reserved.